Moderna: in talks with Japan for Covid-19 vaccine doses
(CercleFinance.com) - Moderna says that it has begun talks with the Japanese Ministry of Health for the potential purchase of 40 million plus doses of mRNA-1273, its experimental Covid-19 vaccine, to help Japan provide vaccines to its population as soon as possible.
Under the terms of the arrangement, the vaccine developed by the US biotechnology group would be distributed in Japan by Takeda Pharmaceutical, starting in the first half of 2021 - if the product receives regulatory approval.
Copyright (c) 2020 CercleFinance.com. All rights reserved.
Under the terms of the arrangement, the vaccine developed by the US biotechnology group would be distributed in Japan by Takeda Pharmaceutical, starting in the first half of 2021 - if the product receives regulatory approval.
Copyright (c) 2020 CercleFinance.com. All rights reserved.